Suppliers are feeling heightened pressure as drug retailers look for ways to drive foot traffic, differentiate, and stay relevant with shoppers. The U.S. retail Drug channel continues to face multiple headwinds that are putting pressure on sales and margins. Highly impacted by post-COVID changing consumer habits and preferences, it’s also experiencing economic and inflationary pressures, labor shortages, online pharmacy disruptors, decreasing reimbursement, and most recently, a disappointing cough/cold season. At the same time, retailers are focused on omnichannel health and wellness as they continue to transform their businesses into one-stop healthcare destinations. A highly complex environment, the Drug channel requires suppliers to embrace a radically new mindset and mindful strategies to win.
In this episode of the MPG Path Forward Podcast, Bryan Gildenberg speaks with former CVS, Walgreens, and Rite Aid veterans and MPG retail leaders to explore the key trends and challenges currently impacting this channel. Hear why a “rinse and repeat” approach no longer works, and gain their insider insights on what is now needed to drive high brand sales performance in this complex landscape.
- Bill Bergin, former Group Vice President of Health and Beauty at Rite Aid
- Luke Rauch, former Walgreens Chief Merchandising Officer
- Sherry Saffert, former CVS Health, Beauty and Personal Care Merchandise and Category Management leader
- Jason Henney, MPG EVP, Drug Retail and Drug Wholesale Sales Strategy & Services
Whether you're a seasoned brand owner or newly venturing into this space, this episode of MPG Path Forward offers invaluable perspectives that can pivot your strategies for accelerated growth. For more insights on how MPG can help your business win in the Drug channel, connect with @Jason Henney at Jason.henney@mpgllc.com